Amniotic Membrane Market Size & Share Report, 2032

Amniotic Membrane Market - By Product, By Application, By End Use – Global Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market segmentation

1.2&nbsp;&nbsp;&nbsp; Market definition

1.3&nbsp;&nbsp;&nbsp; Research design

1.4&nbsp;&nbsp;&nbsp; Market size estimates and calculations

1.5&nbsp;&nbsp;&nbsp; Key trends for market estimates

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Primary research &amp; validation

1.7.1&nbsp;&nbsp;&nbsp; Primary sources

1.7.2&nbsp;&nbsp;&nbsp; Data mining sources

1.7.2.1&nbsp;&nbsp;&nbsp; Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp; Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Product trends

2.3&nbsp;&nbsp;&nbsp; Application trends

2.4&nbsp;&nbsp;&nbsp; End-use trends

2.5&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing demand for regenerative medicine

3.2.1.2&nbsp;&nbsp;&nbsp; Rising incidence of chronic wounds

3.2.1.3&nbsp;&nbsp;&nbsp; Advancements in biotechnology and tissue engineering

3.2.1.4&nbsp;&nbsp;&nbsp; Increasing awareness and acceptance of amniotic membrane products

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Limited shelf life of amniotic membrane products

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory polices

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By application

3.3.3&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.6&nbsp;&nbsp;&nbsp; Technology landscape

3.7&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategic dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2018 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Cryopreserved

5.3&nbsp;&nbsp;&nbsp; Lyophilized

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2018 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Surgical wounds

6.3&nbsp;&nbsp;&nbsp; Ophthalmology

6.4&nbsp;&nbsp;&nbsp; Stem cell biology

6.5&nbsp;&nbsp;&nbsp; Regenerative medicine

6.6&nbsp;&nbsp;&nbsp; Prenatal diagnosis

6.7&nbsp;&nbsp;&nbsp; Orthopedics

6.8&nbsp;&nbsp;&nbsp; Dermatology

6.9&nbsp;&nbsp;&nbsp; Plastic surgery

6.10&nbsp;&nbsp;&nbsp; Dentistry

6.11&nbsp;&nbsp;&nbsp; Gynecology

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2018 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Ambulatory surgical centers (ASCs)

7.4&nbsp;&nbsp;&nbsp; Specialty clinics

7.5&nbsp;&nbsp;&nbsp; Research and academic institutes

7.6&nbsp;&nbsp;&nbsp; Other end-users

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2018 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Amnio Technology, LLC

9.2&nbsp;&nbsp;&nbsp; Applied Biologics LLC

9.3&nbsp;&nbsp;&nbsp; BioTissue Holdings Inc.

9.4&nbsp;&nbsp;&nbsp; Celularity Inc.

9.5&nbsp;&nbsp;&nbsp; Corza Health, Inc.

9.6&nbsp;&nbsp;&nbsp; Integra LifeSciences Holdings Corporation

9.7&nbsp;&nbsp;&nbsp; MiMedx Group, Inc.

9.8&nbsp;&nbsp;&nbsp; Organogenesis Holdings Inc.

9.9&nbsp;&nbsp;&nbsp; Skye Biologics, Inc.

9.10&nbsp;&nbsp;&nbsp; Smith &amp; Nephew plc 
&nbsp;

Amniotic Membrane Market

Get a free sample of this report